Details for Patent: 9,169,307
✉ Email this page to a colleague
Which drugs does patent 9,169,307 protect, and when does it expire?
Patent 9,169,307 protects SYFOVRE and EMPAVELI and is included in two NDAs.
This patent has thirty-three patent family members in eighteen countries.
Summary for Patent: 9,169,307
| Title: | Potent compstatin analogs |
| Abstract: | Compounds comprising peptides and peptidomimetics capable of binding C3 protein and inhibiting complement activation are disclosed. These compounds display greatly improved complement activation-inhibitory activity as compared with currently available compounds. |
| Inventor(s): | Lambris; John D. (Bryn Mawr, PA), Katragadda; Madan (Ypsilanti, MI) |
| Assignee: | The Trustees of the University of Pennsylvania (Philadelphia, PA) |
| Application Number: | 13/007,196 |
|
Patent Claim Types: see list of patent claims | Use; Compound; |
Drugs Protected by US Patent 9,169,307
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apellis Pharms | SYFOVRE | pegcetacoplan | SOLUTION;INTRAVITREAL | 217171-001 | Feb 17, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION BY ADMINISTERING COMPLEMENT INHIBITOR PEGCETACOPLAN | ⤷ Try a Trial | |||
| Apellis Pharms | EMPAVELI | pegcetacoplan | SOLUTION;SUBCUTANEOUS | 215014-001 | May 14, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) BY ADMINISTRATION OF COMPLEMENT INHIBITOR PEGCETACOPLAN | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,169,307
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2006318333 | ⤷ Try a Trial | |||
| Brazil | PI0619023 | ⤷ Try a Trial | |||
| Canada | 2631443 | ⤷ Try a Trial | |||
| Canada | 2971349 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
